OTCMKTS:DCTHD - Delcath Systems Stock Price, Price Target & More

$0.0899 -0.03 (-21.83 %)
(As of 04/19/2018 04:00 PM ET)
Previous Close$0.1150
Today's Range$0.0811 - $0.1340
52-Week Range$0.0811 - $833.0001
Volume7.60 million shs
Average Volume274,582 shs
Market Capitalization$5.48 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.84

About Delcath Systems (OTCMKTS:DCTHD)

Delcath Systems logoDelcath Systems, Inc. is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS). The Company's system delivers and filters melphalan hydrochloride, which is marketed as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan (CHEMOSAT). The Company's focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.

Receive DCTHD News and Ratings via Email

Sign-up to receive the latest news and ratings for DCTHD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolOTCMKTS:DCTHD
CUSIPN/A
Phone+1-212-4892100

Debt

Debt-to-Equity RatioN/A
Current Ratio0.83%
Quick Ratio0.76%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.99 million
Price / Sales0.12
Cash FlowN/A
Price / CashN/A
Book Value($0.71) per share
Price / Book-0.13

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-17,970,000.00
Net Margins-1,278.64%
Return on Equity-3,960.73%
Return on Assets-165.16%

Miscellaneous

Employees43
Outstanding Shares2,590,000

How to Become a New Pot Stock Millionaire

Delcath Systems (OTCMKTS:DCTHD) Frequently Asked Questions

What is Delcath Systems' stock symbol?

Delcath Systems trades on the OTCMKTS under the ticker symbol "DCTHD."

When did Delcath Systems' stock split? How did Delcath Systems' stock split work?

Shares of Delcath Systems reverse split on Monday, November 6th 2017. The 1-350 reverse split was announced on Friday, November 3rd 2017. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 3rd 2017. An investor that had 100 shares of Delcath Systems stock prior to the reverse split would have 0 shares after the split.

How were Delcath Systems' earnings last quarter?

Delcath Systems, Inc. (OTCMKTS:DCTHD) released its earnings results on Friday, November, 11th. The medical device company reported ($231.00) earnings per share for the quarter, topping the Zacks' consensus estimate of ($1,151.50) by $920.50. The medical device company had revenue of $0.44 million for the quarter. Delcath Systems had a negative net margin of 1,278.64% and a negative return on equity of 3,960.73%. During the same period last year, the company posted ($686.00) EPS. View Delcath Systems' Earnings History.

Who are some of Delcath Systems' key competitors?

Who are Delcath Systems' key executives?

Delcath Systems' management team includes the folowing people:
  • Roger G. Stoll Ph.D., Chairman of the Board (Age 74)
  • Jennifer K. Simpson Ph.D., President, Chief Executive Officer, Director (Age 48)
  • Barbra C. Keck, Chief Financial Officer, Secretary (Age 39)
  • John Purpura, Executive Vice President - Global Head of Operations (Age 55)
  • Simon C. Pedder Ph.D., Director (Age 56)
  • William Dodge Rueckert, Independent Director (Age 64)
  • Marco Taglietti M.D., Independent Director (Age 57)

Has Delcath Systems been receiving favorable news coverage?

Media coverage about DCTHD stock has trended somewhat positive this week, according to Accern Sentiment. The research firm identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Delcath Systems earned a media sentiment score of 0.13 on Accern's scale. They also assigned media coverage about the medical device company an impact score of 46.72 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of Delcath Systems?

Shares of DCTHD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Delcath Systems' stock price today?

One share of DCTHD stock can currently be purchased for approximately $0.0899.

How big of a company is Delcath Systems?

Delcath Systems has a market capitalization of $5.48 million and generates $1.99 million in revenue each year. Delcath Systems employs 43 workers across the globe.

How can I contact Delcath Systems?

Delcath Systems' mailing address is 1633 Broadway Ste 22C, NEW YORK, NY 10019-6708, United States. The medical device company can be reached via phone at +1-212-4892100 or via email at [email protected]


MarketBeat Community Rating for Delcath Systems (DCTHD)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  119 (Vote Outperform)
Underperform Votes:  114 (Vote Underperform)
Total Votes:  233
MarketBeat's community ratings are surveys of what our community members think about Delcath Systems and other stocks. Vote "Outperform" if you believe DCTHD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DCTHD will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Delcath Systems (OTCMKTS:DCTHD) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/19/2016 forward)

Earnings

Delcath Systems (OTCMKTS:DCTHD) Earnings History and Estimates Chart

Earnings by Quarter for Delcath Systems (OTCMKTS:DCTHD)

Delcath Systems (OTCMKTS DCTHD) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/11/2016Q3 2016($1,151.50)($231.00)$0.44 millionViewN/AView Earnings Details
8/16/2016Q2($1,543.50)$466.00 million$511.00 millionViewN/AView Earnings Details
5/4/2016Q1($66.50)($28.00)$0.37 millionViewN/AView Earnings Details
3/21/2016Q415($80.50)$0.44 millionViewN/AView Earnings Details
11/10/2015Q3($42.00)$0.40 millionViewN/AView Earnings Details
8/5/2015Q2($105.00)$251.00 million$466.00 millionViewN/AView Earnings Details
3/10/2015Q414($108.50)$0.29 millionViewN/AView Earnings Details
5/7/2014Q114($224.00)($199.50)$0.20 million$0.31 millionViewListenView Earnings Details
3/12/2014Q413($17.50)($14.00)$0.10 million$0.30 millionViewListenView Earnings Details
11/6/2013Q313($28.00)($24.50)$0.30 million$0.07 millionViewListenView Earnings Details
8/6/2013Q2 2013($38.50)($21.00)$0.30 millionViewListenView Earnings Details
5/8/2013Q1 2013($45.50)($52.50)$0.28 million$0.30 millionViewListenView Earnings Details
8/7/2012($105.00)($91.00)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Delcath Systems (OTCMKTS:DCTHD) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Delcath Systems (OTCMKTS DCTHD) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.03%
Insider Trading History for Delcath Systems (OTCMKTS:DCTHD)
Institutional Ownership by Quarter for Delcath Systems (OTCMKTS:DCTHD)

Delcath Systems (OTCMKTS DCTHD) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/23/2015Laura A PhilipsDirectorBuy162,653$0.50$81,326.50View SEC Filing  
7/22/2015William Dodge RueckertDirectorBuy20,000$0.48$9,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Delcath Systems (OTCMKTS DCTHD) News Headlines

Source:
DateHeadline
Summary of Recent Published Research on Delcaths PHP Therapy Presented at Society of Surgical Oncology Annual ...Summary of Recent Published Research on Delcath's PHP Therapy Presented at Society of Surgical Oncology Annual ...
globenewswire.com - March 31 at 4:08 PM
Delcath to Present at Oppenheimer 28th Annual Healthcare Conference - GlobeNewswire (press release)Delcath to Present at Oppenheimer 28th Annual Healthcare Conference - GlobeNewswire (press release)
www.globenewswire.com - March 19 at 4:13 PM
Delcath Announces 2017 Financial Results - GlobeNewswire (press release)Delcath Announces 2017 Financial Results - GlobeNewswire (press release)
globenewswire.com - March 16 at 4:13 PM
Delcath to Present at 30th Annual Roth Conference - GlobeNewswire (press release)Delcath to Present at 30th Annual Roth Conference - GlobeNewswire (press release)
globenewswire.com - March 12 at 4:02 PM
Delcath Announces Commercial Supply Agreement for Melphalan Hydrochloride for Injection with Tillomed Laboratories - GlobeNewswire (press release)Delcath Announces Commercial Supply Agreement for Melphalan Hydrochloride for Injection with Tillomed Laboratories - GlobeNewswire (press release)
globenewswire.com - March 7 at 4:03 PM
Delcath Announces 500th Commercial CHEMOSAT Treatment in Europe - GlobeNewswire (press release)Delcath Announces 500th Commercial CHEMOSAT Treatment in Europe - GlobeNewswire (press release)
globenewswire.com - February 2 at 3:21 PM
Delcath Announces Satisfaction of 2016 Convertible Note - GlobeNewswire (press release)Delcath Announces Satisfaction of 2016 Convertible Note - GlobeNewswire (press release)
globenewswire.com - February 1 at 3:20 PM
Delcath Announces Satisfaction of 2016 Convertible NoteDelcath Announces Satisfaction of 2016 Convertible Note
finance.yahoo.com - February 1 at 3:20 PM
Delcath Announces Special Protocol Agreement Modification With FDA - GlobeNewswire (press release)Delcath Announces Special Protocol Agreement Modification With FDA - GlobeNewswire (press release)
globenewswire.com - January 12 at 4:52 PM
Positive Results From a Multi-Center Analysis of Delcath PHP Therapy Published in Journal of Surgical OncologyPositive Results From a Multi-Center Analysis of Delcath PHP Therapy Published in Journal of Surgical Oncology
finance.yahoo.com - January 9 at 9:49 AM
Delcath Announces Exit from Convertible Note OTC Markets:DCTHD - GlobeNewswire (press release)Delcath Announces Exit from Convertible Note OTC Markets:DCTHD - GlobeNewswire (press release)
globenewswire.com - December 29 at 4:56 PM
Insulet (PODD) and Delcath Systems (DCTHD) Head-To-Head SurveyInsulet (PODD) and Delcath Systems (DCTHD) Head-To-Head Survey
www.americanbankingnews.com - December 18 at 1:34 AM
Insulet (PODD) vs. Delcath Systems (DCTHD) Head to Head SurveyInsulet (PODD) vs. Delcath Systems (DCTHD) Head to Head Survey
www.americanbankingnews.com - December 10 at 11:34 PM
ReWalk Robotics (RWLK) and Delcath Systems (DCTHD) Financial AnalysisReWalk Robotics (RWLK) and Delcath Systems (DCTHD) Financial Analysis
www.americanbankingnews.com - December 10 at 1:52 AM
Head-To-Head Analysis: Wright Medical Group (WMGI) & Delcath Systems (DCTHD)Head-To-Head Analysis: Wright Medical Group (WMGI) & Delcath Systems (DCTHD)
www.americanbankingnews.com - December 8 at 8:40 AM
Delcath Systems (DCTHD) & Insulet (PODD) Head-To-Head SurveyDelcath Systems (DCTHD) & Insulet (PODD) Head-To-Head Survey
www.americanbankingnews.com - December 8 at 1:30 AM
Wright Medical Group (WMGI) & Delcath Systems (DCTHD) Head to Head ContrastWright Medical Group (WMGI) & Delcath Systems (DCTHD) Head to Head Contrast
www.americanbankingnews.com - December 7 at 11:54 PM
Delcath Systems (DCTHD) & Wright Medical Group (WMGI) Head to Head AnalysisDelcath Systems (DCTHD) & Wright Medical Group (WMGI) Head to Head Analysis
www.americanbankingnews.com - December 7 at 9:24 AM
Head to Head Contrast: Delcath Systems (DCTHD) vs. ReWalk Robotics (RWLK)Head to Head Contrast: Delcath Systems (DCTHD) vs. ReWalk Robotics (RWLK)
www.americanbankingnews.com - December 5 at 1:10 AM
Delcath Systems (DCTHD) & Wright Medical Group (WMGI) Critical ComparisonDelcath Systems (DCTHD) & Wright Medical Group (WMGI) Critical Comparison
www.americanbankingnews.com - December 2 at 3:06 PM
Contrasting Delcath Systems (DCTHD) & Wright Medical Group (WMGI)Contrasting Delcath Systems (DCTHD) & Wright Medical Group (WMGI)
www.americanbankingnews.com - December 2 at 5:36 AM
Delcath Systems, Inc. :DCTHD-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017Delcath Systems, Inc. :DCTHD-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 9:57 AM
Contrasting ReWalk Robotics (RWLK) and Delcath Systems (DCTHD)Contrasting ReWalk Robotics (RWLK) and Delcath Systems (DCTHD)
www.americanbankingnews.com - November 29 at 9:12 AM
Insulet (PODD) versus Delcath Systems (DCTHD) Head-To-Head ReviewInsulet (PODD) versus Delcath Systems (DCTHD) Head-To-Head Review
www.americanbankingnews.com - November 28 at 11:40 AM
Critical Contrast: Delcath Systems (DCTHD) versus Insulet (PODD)Critical Contrast: Delcath Systems (DCTHD) versus Insulet (PODD)
www.americanbankingnews.com - November 27 at 12:15 PM
Head-To-Head Comparison: Insulet (PODD) vs. Delcath Systems (DCTHD)Head-To-Head Comparison: Insulet (PODD) vs. Delcath Systems (DCTHD)
www.americanbankingnews.com - November 25 at 9:18 PM
Delcath Enhances Board of Directors With Appointment of Industry Veteran, Dr. Simon Pedder - GlobeNewswire (press release)Delcath Enhances Board of Directors With Appointment of Industry Veteran, Dr. Simon Pedder - GlobeNewswire (press release)
globenewswire.com - November 20 at 9:15 AM
Delcath Enhances Board of Directors With Appointment of Industry Veteran, Dr. Simon PedderDelcath Enhances Board of Directors With Appointment of Industry Veteran, Dr. Simon Pedder
finance.yahoo.com - November 20 at 9:15 AM
Head-To-Head Analysis: Delcath Systems (DCTHD) vs. ReWalk Robotics (RWLK)Head-To-Head Analysis: Delcath Systems (DCTHD) vs. ReWalk Robotics (RWLK)
www.americanbankingnews.com - November 17 at 9:32 PM
Delcath Systems, Inc. (DCTHD)Delcath Systems, Inc. (DCTHD)
finance.yahoo.com - November 16 at 6:24 PM
Delcath Announces Third Quarter 2017 Financial Results - GlobeNewswire (press release)Delcath Announces Third Quarter 2017 Financial Results - GlobeNewswire (press release)
globenewswire.com - November 16 at 1:22 PM
Head-To-Head Review: Delcath Systems (DCTHD) & Wright Medical Group N.V. (WMGI)Head-To-Head Review: Delcath Systems (DCTHD) & Wright Medical Group N.V. (WMGI)
www.americanbankingnews.com - November 16 at 1:06 AM
Reviewing Delcath Systems (DCTHD) and Wright Medical Group N.V. (WMGI)Reviewing Delcath Systems (DCTHD) and Wright Medical Group N.V. (WMGI)
www.americanbankingnews.com - November 15 at 11:38 AM
Delcath Announces Third Quarter 2017 Financial ResultsDelcath Announces Third Quarter 2017 Financial Results
finance.yahoo.com - November 14 at 11:15 PM
Delcath Systems, Inc. (DCTHD) Lowered to Sell at ValuEngineDelcath Systems, Inc. (DCTHD) Lowered to Sell at ValuEngine
www.americanbankingnews.com - November 14 at 4:40 PM

SEC Filings

Delcath Systems (OTCMKTS:DCTHD) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Delcath Systems (OTCMKTS DCTHD) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.